Market Research Logo

Peritonitis - Pipeline Review, H2 2018

Peritonitis - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis - Pipeline Review, H2 2018, provides an overview of the Peritonitis (Gastrointestina


Introduction
Global Markets Direct Report Coverage
Peritonitis - Overview
Peritonitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Peritonitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Peritonitis - Companies Involved in Therapeutics Development
GlaxoSmithKline Plc
Nosopharm SAS
Oncodesign SA
SynAct Pharma AB
Peritonitis - Drug Profiles
AP-1189 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ARV-1502 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ceforanide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
molgramostim - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NOSO-502 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit RIP2 for Gastrointestinal Disorders, Polyarthritis and Rheumatoid Arthritis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SRT-3025 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peritonitis - Dormant Projects
Peritonitis - Product Development Milestones
Featured News & Press Releases
Jun 19, 2016: Reponex Pharmaceuticals: The Danish Medicines Agency has approved the clinical trial protocol for the peritonitis project
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Peritonitis, H2 2018
Number of Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Peritonitis - Pipeline by GlaxoSmithKline Plc, H2 2018
Peritonitis - Pipeline by Nosopharm SAS, H2 2018
Peritonitis - Pipeline by Oncodesign SA, H2 2018
Peritonitis - Pipeline by SynAct Pharma AB, H2 2018
Peritonitis - Dormant Projects, H2 2018
List of Figures
Number of Products under Development for Peritonitis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Targets, H2 2018
Number of Products by Stage and Targets, H2 2018
Number of Products by Mechanism of Actions, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report